01470nas a2200217   4500000000100000008004100001653002500042653002900067653002500096653001000121653001800131100001300149700001400162700001200176245012100188856005500309300001100364490000900375520085400384022001401238       2012                            d10aMorbidity management10aMass drug administration10aLymphatic filariasis10aIndia10aElephantiasis1 aKumari K1 aYuvaraj J1 aDas L K00aIssues in delivering morbidity management for lymphatic filariasis elimination: a study in Pondicherry, South India.  uhttp://www.hindawi.com/journals/tswj/2012/372618/   a3726180 v20123 a<p>Lymphatic filariasis is a vector borne parasitic disease causing long term disability. The Global Programme to Eliminate Lymphatic Filariasis aims to achieve its objective through two strategies; Mass Drug Administration (MDA) to interrupt transmission and Morbidity Management (MM) to manage disability for those already affected. MDA is going on in full swing in endemic areas; but MM is lagging behind. An exploratory study was conducted in Pondicherry through focus group discussions to find out whether there are delivery issues if any, in the MM programme and get suggestions from end users. The study results show that MM has not received the same attention as MDA and there are shortcomings in the delivery mechanism of the programme. The importance of these findings are discussed and suggestions given for improving the programme.</p>
  a1537-744X